The mean densities for c-Myc in the cells from lower- and higher-risk MDS patients were 0.13 ± 0.00 vs. 0.21 ± 0.01, respectively (p < 0.001), whereas that obtained for the cells from the normal donors was 0.12 ± 0.00. This evidence concerns the gene MYC and myelodysplastic syndrome.